how to use
Night-time use only.
Start with the lowest concentration strength first and slowly transition to the higher concentrations.
Targeted spot treatment regime: apply a thin layer of serum as a spot treatment to affected areas every second to third night.
Allow for the serum to fully absorb and then follow with your normal night-time skincare regime such as sk.in flash, sk.in bounce, and sk.in marvel.
Ideal spot treatment areas:
– Hyperpigmentation
– Acne, blemishes and breakouts;
– Fine lines and wrinkles;
– Congestion and enlarged pores;
– Oily t-zone.
Full face and neck treatment regime: for a complete high concentration face and neck treatment, apply 1 ml once or twice weekly to the entire face and neck. Allow for the serum to fully absorb before applying the rest of your skin regime such as sk.in marvel. Do not use with any other retinol or vitamin A based serums.
ingredients
Hydroxypinacolone retinoate 4%, Hyaluronic Acid 2%, Acetyl Hexapeptide-8 10%.
INCI List:
Aqua, Dimethyl Isosorbide, Acetyl Hexapeptide-8, Hydroxypinacolone Retinoate, Cetyl Alcohol, Glyceryl Stearate, PEG-75 Stearate, Ceteth-20, Steareth-20, Sodium Hyaluronate, Isostearyl Alcohol, Butylene Glycol Cocoate, Ethylcellulose, C12- 15 Alkane, Ethylhexylglycerin, Phenoxyethanol.
*no parabens have been used in sk.in formulations.
precautions
sk.in avenge | HPR contains extremely high concentrations of hydroxypinacolone retinoate. Dr. Alek Nikolic recommends that you introduce this product slowly into your skin care regime. sk.in avenge | HPR must not be used if pregnant, breast feeding, planning to become pregnant, or using oral vitamin A medication (such as Roaccutane). With excessive use one can experience dry, sensitive, flaking skin. Do not use on overly sensitive skin types or on compromised skin such as burns, damaged skin, or allergic skin conditions (eczema, dermatitis). Hydroxypinacolone retinoate can increase skin sensitivity to the sun, so remember to always apply an SPF of 30 or higher during the day.
Reviews
There are no reviews yet.